Related references
Note: Only part of the references are listed.Porphyrin-Based Metal-Organic Frameworks for Biomedical Applications
Jiajie Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Polydopamine (PDA)-activated cobalt sulfide nanospheres responsive to tumor microenvironment (TME) for chemotherapeutic-enhanced photothermal therapy
Mengmeng Hou et al.
CHINESE CHEMICAL LETTERS (2021)
Effective Eradication of Tumors by Enhancing Photoacoustic-Imaging-Guided Combined Photothermal Therapy and Ultrasonic Therapy
Caina Xu et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma
Changrong Wang et al.
BIOMATERIALS (2021)
In situ vaccination and gene-medeiated PD-L1 blockade for enhanced tumor immunotherapy
Yingying Hu et al.
CHINESE CHEMICAL LETTERS (2021)
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
Bozhao Li et al.
NANO LETTERS (2021)
Reshaping Antitumor Immunity with Chemo-Photothermal Integrated Nanoplatform to Augment Checkpoint Blockade-Based Cancer Therapy
Tong Gao et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Integration of immunogenic activation and immunosuppressive reversion using mitochondrial-respiration-inhibited platelet-mimicking nanoparticles
Xiaoli Mai et al.
BIOMATERIALS (2020)
Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles
Suping Li et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger
Yingying Hu et al.
BIOMATERIALS (2020)
Mitoxantrone as photothermal agents for ultrasound/fluorescence imaging-guided chemo-phototherapy enhanced by intratumoral H2O2-Induced CO
Ya Wang et al.
BIOMATERIALS (2020)
An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles
Jiayan Wu et al.
SCIENCE ADVANCES (2020)
Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition
Yao Li et al.
ACS NANO (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2019)
Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis
Pengcheng Zhang et al.
ADVANCED MATERIALS (2019)
Cyanine-Assisted Exfoliation of Covalent Organic Frameworks in Nanocomposites for Highly Efficient Chemo-Photothermal Tumor Therapy
Kui Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment
Yayu Wen et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR-II Light
Mei Wen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
Chanyoung Song et al.
NATURE COMMUNICATIONS (2019)
Multifunctional Two-Dimensional Core-Shell MXene@Gold Nanocomposites for Enhanced Photo-Radio Combined Therapy in the Second Biological Window
Wantao Tang et al.
ACS NANO (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy
Madiha Saeed et al.
THERANOSTICS (2019)
The pro-tumorigenic host response to cancer therapies
Yuval Shaked
NATURE REVIEWS CANCER (2019)
Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
Min Zhang et al.
RSC ADVANCES (2019)
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma
Qi Liu et al.
ACS NANO (2018)
Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment
Kyun-Do Kim et al.
NATURE COMMUNICATIONS (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Hyaluronic acid for anticancer drug and nucleic acid delivery
Franco Dosio et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Rationale for anti-OX40 cancer immunotherapy
Sandrine Aspeslagh et al.
EUROPEAN JOURNAL OF CANCER (2016)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Cationic Conjugated Polymer/Fluoresceinamine-Hyaluronan Complex for Sensitive Fluorescence Detection of CD44 and Tumor-Targeted Cell Imaging
Yanqin Huang et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
Kui S. Voo et al.
JOURNAL OF IMMUNOLOGY (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Sid P. Kerkar et al.
CANCER RESEARCH (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
OX40 controls functionally different T cell subsets and their resistance to depletion therapy
Alexander Kroemer et al.
JOURNAL OF IMMUNOLOGY (2007)
Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity:: a novel regulatory role for OX40 and its comparison with GITR
B Valzasina et al.
BLOOD (2005)
Share Paper
